CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-09 | Karkus Ted William CEO & CHAIRMAN | Grant or award · warrants | +500,000 | 500,000 | ||
| 2025-02-17 | Hollenshead Stuart Chief Operating Officer | Grant or award · Option (right to buy) | +500,000 | 500,000 | ||
| 2025-02-14 | Hirsch Warren Director | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2025-02-14 | GLECKEL LOUIS MD Director | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2024-03-17 | Karkus Ted William CEO & CHAIRMAN | Grant or award · Option (right to buy) | +400,000 | 400,000 | ||
| 2024-03-17 | Hirsch Warren Director | Grant or award · Option (right to buy) | +70,000 | 70,000 | ||
| 2024-03-17 | GLECKEL LOUIS MD Director | Grant or award · Option (right to buy) | +70,000 | 70,000 | ||
| 2024-03-17 | Barr Jason Michael Director | Grant or award · Option (right to buy) | +70,000 | 70,000 | ||
| 2024-03-17 | Karkus Ted William CEO & CHAIRMAN | Grant or award · Option (right to buy) | −400,000 | 400,000 | ||
| 2024-01-01 | Latkin Jed Director | Grant or award · Option (right to buy) | +500,000 | 500,000 | ||
| 2023-06-19 | Hirsch Warren Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-19 | Barr Jason Michael Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-19 | GLECKEL LOUIS MD Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-16 | Hirsch Warren Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-16 | GLECKEL LOUIS MD Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2023-06-16 | Barr Jason Michael Director | Grant or award · Option (right to buy) | +40,000 | 40,000 | ||
| 2023-04-05 | Karkus Ted William CEO & CHAIRMAN | Gift | −50,000 | 3,433,750 | ||
| 2023-04-05 | Karkus Ted William CEO & CHAIRMAN | Gift | +50,000 | 150,000 | ||
| 2023-04-04 | Morse Robert A. Jr. CHIEF FINANCIAL OFFICER | Grant or award · Option (right to buy) | +50,000 | 50,000 | ||
| 2023-04-03 | Karkus Ted William CEO & CHAIRMAN | Gift | −100,000 | 3,483,750 |
Page 1 of 8 · 148 trades